Benzinga | Nov 1, 2021 07:07AM EDT

Theseus Pharmaceuticals Announces FDA Clearance Of Investigational New Drug Application For THE-630, A Pan-Variant KIT Inhibitor In Development For The Treatment Of Gastrointestinal Stromal Tumors

https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-announces-fda-clearan[...]ment-of-gastrointestinal-stromal-tumors-gist-301412529.html